* Encompass Health Corp EHC.N EHC is expected to show a
fall
in quarterly revenue when it reports results on February 7.
* The Birmingham Alabama-based company is expected to
report a
15.0% decrease in revenue to $1.121 billion from $1.32 billion a
year ago, according to the mean estimate from 9 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Encompass Health
Corp is
for earnings of 83 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Encompass
Health
Corp is $68, above its last closing price of $61.49.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.65 0.64 0.67 Beat 5
Jun. 30 2022 0.92 0.97 0.89 Missed -8
Mar. 31 2022 0.90 0.92 0.97 Beat 5.7
Dec. 31 2021 1.04 1.05 0.97 Missed -7.5
Sep. 1.06 1.06 1.03 Missed -2.7
30 2021
Jun. 30 2021 0.98 0.97 1.17 Beat 20.2
Mar. 31 2021 0.83 0.82 1.05 Beat 27.8
Dec. 31 2020 0.86 0.85 0.93 Beat 8.8
This summary was machine generated February 4 at 01:48 GMT. All
figures in US dollars unless otherwise stated